The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
The Pepper Street multi-storey car park development will create 50 jobs
Cheshire West and Chester Council will begin enforcement of moving traffic offences at four locations from 20 May, to reduce dangerous manoeuvres, congestion and disruption on the road network.
Cheshire is set to become home to the first advanced nuclear fuel facility in Europe to establish an energy supply chain not reliant on Russia, the Government has said.